Dallas, Texas 01/31/2014 (FINANCIALSTRENDS) – Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) President and Chief Executive Officer Joseph G. Oliveto announced the appointment of Mr Keith W. Schmidt as the Chief Commercial Officer on 30th January. The CCO will have the responsibilities of helping the development stage drug maker progress its lead...
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) posted operational and financial report for the first quarter closed March 31, 2017. Net loss came at $14.2 million against net loss of $15.7 million for the comparable quarter in 2016. The updates Earlier in March, Dicerna finalized a stock purchase deal with a syndicate of new...
Shares of Novadaq Technologies Inc. (NASDAQ:NVDQ) are currently poised at -0.26% from the open today and are hovering around at $11.65. More than 8,269,464 shares have traded hands versus an average trading volume of 254.69K. At the current PPS, the market capiralization stands at $346.82M. The stock prices of...
Savara Inc (NASDAQ:SVRA) has announced that it has successfully closed its much awaited merger with Mast Therapeutics Inc (NYSE:MSTX). As a result of the transaction, the stockholders of SVRA have become the majority owners of MSTX and Mast has merged with the company. As per the merger agreement, Savara...
Shares of NewLink Genetics Corporation (NASDAQ:NLNK) last traded at $6.24. (NASDAQ:NLNK) performance year to date is -39.30%. The 200 day simple moving average is -56.19%. The 200 SMA is considered a major indicator by market analysts and traders for determining the long-term trend. The price in the market that...
Novavax, Inc. (NASDAQ:NVAX) has promoted Dr. James F. Cummings to VP, Clinical Development & Translational Medicine role with the company. Dr. Cummings had joined company as Senior Director of Clinical Development in 2015, with a key focus on developing company’s programs within growing infectious disease. The buzz Prior to that, Dr....
Dallas, Texas 04/03/2014 (FINANCIALSTRENDS) –  Research examiners at Citigroup Inc. lifted their value focus on shares of Allergan, Inc.(NYSE:AGN) from $130.00 to $140.00 in a report discharged on Friday. The firm presently has a "purchase" rating on the stock. Citigroup Inc. Target value might show a potential upside of 12.81%...
Novavax, Inc. (NASDAQ:NVAX) revenue in Q1 2017 jumped 35% to $5.7 million, as against $4.2 million for the equivalent period in 2016, mainly due to increased revenue posted under the BMGF grant pertaining to ongoing Prepare clinical study. Net Loss came at $43.9 million in Q1 2017 against a...
Dallas, Texas 02/25/2014 (FINANCIALSTRENDS) – Delcath Systems, Inc.(NASDAQ:DCTH)  is a leading pharmaceutical which also offers a variety of medical equipment. The company also offers development stage special purpose drugs which are essential in treating cancers. The specialty of this drug maker is in treating cancer of the liver. Delcath Systems, Inc.(NASDAQ:DCTH) has brought...
Shares of Cara Therapeutics, Inc. (NASDAQ:CARA) are currently poised at 1.05% from the open today and are hovering around at $27.15. More than 1,433,399 shares have traded hands versus an average trading volume of 2.10M. At the current PPS, the market capiralization stands at $810.32M. The stock prices of...

Subscribe to our mailing list

* indicates required

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play